Principal Financial Group Inc Pacira Bio Sciences, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$11.7 - $28.46 $109,149 - $265,503	-9,329 Reduced 3.63%	247,427 $3.73 Million
Q2 2024 Jul 29, 2024	SELL	$25.5 - $31.51 $223,915 - $276,689	-8,781 Reduced 3.31%	256,756 $7.35 Million
Q1 2024 Apr 29, 2024	BUY	$27.7 - $35.48 $70,718 - $90,580	2,553 Added 0.97%	265,537 $7.76 Million
Q4 2023 Feb 07, 2024	SELL	$26.32 - $34.31 $21,292 - $27,756	-809 Reduced 0.31%	262,984 $8.87 Million
Q3 2023 Nov 02, 2023	SELL	$30.68 - $40.09 $231,879 - $303,000	-7,558 Reduced 2.79%	263,793 $8.09 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $47.5 $471,293 - $619,780	-13,048 Reduced 4.59%	271,351 $10.9 Million
Q1 2023 May 09, 2023	SELL	$35.53 - $43.38 $251,481 - $307,043	-7,078 Reduced 2.43%	284,399 $11.6 Million
Q4 2022 Feb 09, 2023	SELL	$38.19 - $57.45 $563,798 - $848,134	-14,763 Reduced 4.82%	291,477 $11.3 Million
Q3 2022 Nov 09, 2022	SELL	$51.24 - $58.89 $2.02 Million - $2.33 Million	-39,503 Reduced 11.43%	306,240 $16.3 Million
Q2 2022 Aug 10, 2022	BUY	$51.49 - $81.64 $204,672 - $324,519	3,975 Added 1.16%	345,743 $20.2 Million
Q1 2022 May 09, 2022	SELL	$60.03 - $76.49 $1.23 Million - $1.57 Million	-20,468 Reduced 5.65%	341,768 $26.1 Million
Q4 2021 Feb 09, 2022	SELL	$47.97 - $62.21 $1.44 Million - $1.87 Million	-30,066 Reduced 7.66%	362,236 $21.8 Million
Q3 2021 Nov 09, 2021	BUY	$54.64 - $61.3 $154,412 - $173,233	2,826 Added 0.73%	392,302 $22 Million
Q2 2021 Aug 10, 2021	SELL	$59.18 - $69.99 $818,636 - $968,171	-13,833 Reduced 3.43%	389,476 $23.6 Million
Q1 2021 May 10, 2021	BUY	$59.31 - $78.82 $464,219 - $616,924	7,827 Added 1.98%	403,309 $28.3 Million
Q4 2020 Feb 08, 2021	SELL	$50.47 - $66.26 $1.27 Million - $1.67 Million	-25,191 Reduced 5.99%	395,482 $23.7 Million
Q3 2020 Nov 06, 2020	BUY	$51.97 - $63.0 $1.94 Million - $2.36 Million	37,402 Added 9.76%	420,673 $25.3 Million
Q2 2020 Aug 05, 2020	BUY	$30.8 - $52.47 $283,945 - $483,720	9,219 Added 2.46%	383,271 $20.1 Million
Q1 2020 May 12, 2020	SELL	$28.4 - $50.7 $321,885 - $574,633	-11,334 Reduced 2.94%	374,052 $12.5 Million
Q4 2019 Feb 05, 2020	BUY	$36.31 - $46.83 $409,358 - $527,961	11,274 Added 3.01%	385,386 $17.5 Million
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $11.9 Million - $15 Million	333,782 Added 827.63%	374,112 $14.2 Million
Q2 2019 Aug 12, 2019	BUY	$36.57 - $47.97 $1 Million - $1.32 Million	27,442 Added 212.93%	40,330 $1.75 Million
Q1 2019 May 10, 2019	BUY	$36.47 - $42.17 $33,807 - $39,091	927 Added 7.75%	12,888 $490,000
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $5,494 - $6,937	-133 Reduced 1.1%	11,961 $515,000
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $159,125 - $251,888	4,844 Added 66.81%	12,094 $594,000
Q1 2018 May 14, 2018	SELL	$29.98 - $46.35 $119,500 - $184,751	-3,986 Reduced 35.48%	7,250 $226,000
Q4 2017 Feb 13, 2018	BUY	$31.85 - $46.95 $357,866 - $527,530	11,236	11,236 $512,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account